Patents by Inventor Chalil Abu-Gnim

Chalil Abu-Gnim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diclofenac compositions for the treatment of skin disorders
    Publication number: 20050137164
    Abstract: Novel NSAID pharmaceutical compositions and methods for the treatment of skin disease and disorders such as actinic keratosis using same are disclosed.
    Type: Application
    Filed: September 22, 2004
    Publication date: June 23, 2005
    Inventors: Moshe Arkin, Amira Zeevi, Stephen Cherkez, Eilon Asculai, Chalil Abu-Gnim, Ido Yosha, Michal Arnon, Hila Ohayon-Tsahor, Oren Chen, Galia Fridler
  • Foamable compositions, processes of preparing same and uses thereof
    Publication number: 20050069499
    Abstract: A foamable composition being devoid of CFCs and buffer, which produces quick-breaking foam and optionally comprises pharmaceutically active ingredients such as corticosteroids is disclosed. Methods of treatment using the same and processes of manufacturing the same are also disclosed.
    Type: Application
    Filed: March 30, 2004
    Publication date: March 31, 2005
    Inventors: Moshe Arkin, Rina Uzan, Natalie Grabarnick, Benjamin Schneider, Stephen Cherkez, Eilon Asculai, Amira Zeevi, Chalil Abu-Gnim
  • Pharmaceutical composition and method for transdermal drug delivery
    Publication number: 20050042268
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes urea and/or a derivative thereof as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 24, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi
  • Pharmaceutical composition and method for transdermal drug delivery
    Publication number: 20050025833
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes a quaternary ammonium compound as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 3, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi
  • Pharmaceutical composition and method for transdermal drug delivery
    Publication number: 20050020552
    Abstract: A pharmaceutical composition for transdermal administration of a hormone (e.g., testosterone), which includes isostearic acid as a penetration enhancer, and methods utilizing same for treating medical conditions in which elevating a hormone serum level is beneficial are disclosed.
    Type: Application
    Filed: July 15, 2004
    Publication date: January 27, 2005
    Inventors: Chaim Aschkenasy, Oren Chen, Rami Boochnik, Eilon Asculai, Chalil Abu-Gnim, Amira Zeevi
  • Pharmaceutical compositions containing donepezil hydrochloride
    Patent number: 6734195
    Abstract: The invention provides a pharmaceutical composition for the treatment of dementia or Alzheimer's disease in which the active therapeutical agent is donepezil hydrochloride in an amorphous state.
    Type: Grant
    Filed: August 1, 2002
    Date of Patent: May 11, 2004
    Assignee: Chemagis Ltd.
    Inventors: Alexander Weisman, Chalil Abu Gnim, Rina Uzan, Joseph Kaspi
  • PHARMACEUTICAL COMPOSITIONS CONTAINING DONEPEZIL HYDROCHLORIDE
    Publication number: 20040002517
    Abstract: The invention provides a pharmaceutical composition for the treatment of dementia or Alzheimer's disease in which the active therapeutical agent is donepezil hydrochloride in an amorphous state.
    Type: Application
    Filed: August 1, 2002
    Publication date: January 1, 2004
    Applicant: Chemagis Ltd.
    Inventors: Alexander Weisman, Chalil Abu Gnim, Rina Uzan, Joseph Kaspi
  • Pharmaceutical compositions containing mupirocin
    Patent number: 6489358
    Abstract: The invention provides stable pharmaceutical preparations for topical and nasal uses, comprising Mupirocin calcium amorphous as an anti-microbial active agent therein, dissolved in a pharmaceutically acceptable solvent providing stability therefore.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: December 3, 2002
    Assignee: Agis Industries (1983) Ltd.
    Inventors: Ilana Lavon, Amira Zeevi, Stephen Cherkez, Moshe Arkin, Joseph Kaspi, Chalil Abu-Gnim, Yoav Racchav
  • Pharmaceutical compositions containing mupirocin
    Publication number: 20020028843
    Abstract: The invention provides stable pharmaceutical preparations for topical and nasal uses, comprising Mupirocin calcium amorphous as an anti-microbial active agent therein, dissolved in a pharmaceutically acceptable solvent providing stability therefore.
    Type: Application
    Filed: July 18, 2001
    Publication date: March 7, 2002
    Inventors: Ilana Lavon, Amira Zeevi, Stephen Cherkez, Moshe Arkin, Joseph Kaspi, Chalil Abu-Gnim, Yoav Racchav
  • Pharmaceutical compositions containing mupirocin
    Patent number: 6013657
    Abstract: The invention provides a chemically stable composition comprising a therapeutically effective amount of mupirocin, in a carrier selected from the group consisting of oleyl alcohol, castor oil and a mixture thereof, the composition further optionally comprising a pharmaceutically acceptable base.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: January 11, 2000
    Assignee: AGIS Industries Ltd.
    Inventors: Ilana Lavon, Chalil Abu-Gnim, Amira Zeevi, Yoav Raechav, Shifra Katz, Joseph Kaspi